A detailed history of Retirement Planning CO Of New England, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Retirement Planning CO Of New England, Inc. holds 11,045 shares of GILD stock, worth $996,148. This represents 0.47% of its overall portfolio holdings.

Number of Shares
11,045
Previous 12,342 10.51%
Holding current value
$996,148
Previous $846,000 9.34%
% of portfolio
0.47%
Previous 0.47%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$66.59 - $83.99 $86,367 - $108,935
-1,297 Reduced 10.51%
11,045 $925,000
Q2 2024

Aug 08, 2024

BUY
$63.15 - $72.88 $54,182 - $62,531
858 Added 7.47%
12,342 $846,000
Q1 2024

May 06, 2024

BUY
$71.58 - $87.29 $40,371 - $49,231
564 Added 5.16%
11,484 $841,000
Q4 2023

Feb 12, 2024

BUY
$73.27 - $83.09 $45,134 - $51,183
616 Added 5.98%
10,920 $884,000
Q3 2023

Nov 13, 2023

SELL
$73.94 - $80.67 $43,624 - $47,595
-590 Reduced 5.42%
10,304 $772,000
Q2 2023

Aug 11, 2023

BUY
$76.01 - $86.7 $760 - $867
10 Added 0.09%
10,894 $839,000
Q1 2023

Apr 21, 2023

SELL
$77.31 - $88.08 $4,561 - $5,196
-59 Reduced 0.54%
10,884 $903,000
Q4 2022

Feb 03, 2023

BUY
$62.32 - $89.47 $8,724 - $12,525
140 Added 1.3%
10,943 $939,000
Q3 2022

Oct 19, 2022

BUY
$59.54 - $68.01 $5,477 - $6,256
92 Added 0.86%
10,803 $666,000
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $121,673 - $137,041
-2,108 Reduced 16.44%
10,711 $662,000
Q1 2022

May 06, 2022

BUY
$57.92 - $72.58 $70,488 - $88,329
1,217 Added 10.49%
12,819 $762,000
Q4 2021

Feb 08, 2022

BUY
$64.88 - $73.64 $752,737 - $854,371
11,602 New
11,602 $842,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Retirement Planning CO Of New England, Inc. Portfolio

Follow Retirement Planning CO Of New England, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Planning CO Of New England, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Retirement Planning CO Of New England, Inc. with notifications on news.